ContraVac, Inc., headquartered in the United States, is a pioneering company in the reproductive health industry, specialising in innovative solutions for male fertility. Founded in 2015, ContraVac has made significant strides in developing advanced diagnostic tools, including its flagship product, SpermCheck, which offers a user-friendly at-home testing option for sperm quality. With a commitment to enhancing reproductive health, ContraVac operates primarily in North America and has expanded its reach into international markets. The company is recognised for its unique approach to male fertility testing, providing accurate and accessible solutions that empower individuals and couples on their fertility journeys. ContraVac's dedication to research and development has positioned it as a leader in the field, contributing to a growing awareness of male reproductive health issues.
We don't have data for ContraVac, Inc., but we can show you information about their parent organization instead.
View parent company